<DOC>
	<DOCNO>NCT00955890</DOCNO>
	<brief_summary>Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Chemoprotective drug , dexrazoxane , may protect normal cell side effect chemotherapy . Monoclonal antibody trastuzumab locate tumor cell either kill deliver tumor-killing substance without harm normal cell . Radiation therapy use high-energy x-rays damage tumor cell . CTnT/cTnI/ANP/BNP prove used biomarker drug relate cardiotoxicity . There excellent correlation total cumulative dose doxorubicin , severity result cardiomyopathy , level serum troponin-T .</brief_summary>
	<brief_title>Dexrazoxane Protective Agent Anthracycline Treated Breast Cancer</brief_title>
	<detailed_description>Patients breast cancer receive anthracycline chemotherapy randomize 3 group : chemotherapy plus low dose dexrazoxane , chemotherapy plus middle dose dexrazoxane , chemotherapy only.Every patient receive least 2 cycle anthracycline chemotherapy .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Dexrazoxane</mesh_term>
	<mesh_term>Razoxane</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm primary infiltrating adenocarcinoma breast Confirmed core needle biopsy incisional biopsy surgery Experienced grade 1 cardiac toxicity prior anthracyclinebased chemotherapy At least 2 cycle anthracycline base chemotherapy need Accumulated dose EPI ≥1000mg/m2 , ADM≥550mg/m2 With follow risk factor : Uncontrolled severe cardiovascular disease ( e.g. , myocardial infarction within past 6 month , congestive heart failure treat medication , uncontrolled hypertension ) ; Prior Concurrent radiation heart Pregnant nursing Other currently active malignancy except nonmelanoma skin cancer Uncontrolled severe bleeding , diarrhea , intestinal obstruction Grade 2 Cardiac Toxicity ( CTC AE3.0 )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>cardioprotection</keyword>
	<keyword>anthracycline chemotherapy</keyword>
	<keyword>breast cancer</keyword>
</DOC>